A new study shows that the cancer protein MCL1 connects two key hallmarks of cancer: resistance to cell death and altered ...
A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides ...
AZoLifeSciences on MSN
Protein MCL1 emerges as a central regulator of cancer metabolism
The researchers have succeeded in tracing two classic hallmarks of cancer – the evasion of apoptosis (a form of programmed cell death) and the dysregulation of energy metabolism – back to a common ...
Neurodegenerative disorders are pressing global health challenges that stem from progressive neuronal dysfunction and loss. While the central roles of ...
Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...
A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.
A study published in iMetaMed reveals that the mTOR inhibitor Everolimus treats ulcerative colitis through a two-pronged approach: inhibiting the CLEC4E inflammatory pathway in macrophages and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback